DBV lays off employees, scales down programs after receiving no word from FDA
For years, it was a two-company race to develop the first treatment for peanut allergy. Then in January, Aimmune won approval for its peanut …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
